GPT and cholestasis: GLP1-RAs use was associated with significantly improved levels of serum hepatocellular enzymes; AST and ALT (p < 0.001), meanwhile markers of cholestasis (ALP, bilirubin) were significantly elevated in comparison to control comparators (p < 0.001).